Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Human Caspase-1 Antibody, R&D Systems™

Mouse Monoclonal Antibody
Supplier: R&D Systems MAB6215SP
missing translation for 'nonReturnableMessage'
missing translation for 'returnPolicyLabel'
Description
Caspase-1 Monoclonal specifically detects Caspase-1 in Human samples. It is validated for Western Blot, Immunocytochemistry.Specifications
Caspase-1 | |
Monoclonal | |
LYOPH | |
Western Blot 0.1 ug/mL, Immunocytochemistry 8-25 ug/mL | |
P29466 | |
CASP1 | |
E.coli-derived recombinant human Caspase-1 Asn120-Asp297 Accession # P29466 | |
25 μg | |
Primary | |
Detects human Caspase-1 in direct ELISAs and Western blots. | |
Human | |
Purified |
Western Blot, Immunocytochemistry | |
661228 | |
Unconjugated | |
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative | |
CASP1, CASP-1, CASP1 nirs variant 1, caspase 1, apoptosis-related cysteine peptidase, caspase-1, Caspase1, Caspase-1 subunit p10, Caspase-1 subunit p20, EC 3.4.22.36, EC:3.4.22.36, ICE, IL-1 beta-converting enzyme, IL1BC, IL-1BC, IL1BCE, IL1B-convertase, interleukin 1, beta, convertase, interleukin 1-B converting enzyme, Interleukin-1 beta convertase, Interleukin-1 beta-converting enzyme, p45 | |
Mouse | |
Protein A or G purified from hybridoma culture supernatant | |
RUO | |
834 | |
Sterile PBS to a final concentration of 0.5 mg/mL. | |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution. | |
IgG2a |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
For Research Use Only
Spot an opportunity for improvement?Share a Content Correction